Siglec-G/10 in self-nonself discrimination of innate and adaptive immunity

Glycobiology

Volumn 24, Issue 9, 2014, Pages 800-806

  Chen, Guo Yun ^a,b   Brown, Nicholas K ^a   Zheng, Pan ^a   Liu, Yang ^a  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

DAMP; PAMP; self nonself; Siglec G

Indexed keywords

ANTIGEN; CD24 ANTIGEN; HEAT SHOCK PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN M ANTIBODY; INTERFERON; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN; SIALIC ACID BINDING IMMUNOGLOBULIN LIKE LECTIN G/10; SIALIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; GENE MUTATION; HUMAN; IMMUNE EVASION; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA VIRUS; RNA VIRUS INFECTION; SEPSIS; TISSUE INJURY; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM;

ADAPTIVE IMMUNITY; ANIMALS; ANTIGENS, CD24; HUMANS; IMMUNITY, INNATE; SIALIC ACID BINDING IMMUNOGLOBULIN-LIKE LECTINS; SIALIC ACIDS;

EID: 84905494103     PISSN: 09596658     EISSN: 14602423     Source Type: Journal    
DOI: 10.1093/glycob/cwu068     Document Type: Article

References (62)

1. Andersson U, Harris HE. 2010. The role of HMGB1 in the pathogenesis of rheumatic disease. Biochim Biophys Acta. 1799:141-148.
2. Angata T, Hingorani R, Varki NM, Varki A. 2001. Cloning and characterization of a novel mouse Siglec, mSiglec-F: Differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters. J Biol Chem. 276:45128-45136.
3. Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, Criollo A, Mignot G, Maiuri MC, Ullrich E, Saulnier P, et al. 2007. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med. 13:1050-1059.
4. Bandala-Sanchez E, Zhang Y, Reinwald S, Dromey JA, Lee BH, Qian J, Bohmer RM, Harrison LC. 2013. T cell regulation mediated by interaction of soluble CD52 with the inhibitory receptor Siglec-10. Nat Immunol. 14:741-748.
5. Blixt O, Han S, Liao L, Zeng Y, Hoffmann J, Futakawa S, Paulson JC. 2008. Sialoside analogue arrays for rapid identification of high affinity siglec ligands. J Am Chem Soc. 130:6680-6681.
6. Bochner BS, Alvarez RA, Mehta P, Bovin NV, Blixt O, White JR, Schnaar RL. 2005. Glycan array screening reveals a candidate ligand for Siglec-8. J Biol Chem. 280:4307-4312.
7. Brenner S, Drewel D, Steinbart T, Weisel F, Hartel E, Potzsch S, Welzel H, Brandl A, Yu P, Mudde GC, et al. 2011. A hypomorphic IgH-chain allele affects development of B-cell subsets and favours receptor editing. EMBO J. 30:2705-2718.
8. Carl JW, Jr, Liu JQ, Joshi PS, El-Omrani HY, Yin L, Zheng X, Whitacre CC, Liu Y, Bai XF. 2008. Autoreactive T cells escape clonal deletion in the thymus by a CD24-dependent pathway. J Immunol. 181:320-328.
9. Carlin AF, Uchiyama S, Chang YC, Lewis AL, Nizet V, Varki A. 2009. Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response. Blood. 113:3333-3336.
10. Casey SC, Nelson EL, Turco GM, Janes MR, Fruman DA, Blumberg B. 2011. B-1 cell lymphoma in mice lacking the steroid and xenobiotic receptor, SXR. Mol Endocrinol. 25:933-943.
11. Chen GY, Chen X, King S, Cavassani KA, Cheng J, Zheng X, Cao H, Yu H, Qu J, Fang D, et al. 2011. Amelioration of sepsis by inhibiting sialidasemediated disruption of the CD24-SiglecG interaction. Nat Biotechnol. 29:428-435.
12. Chen W, Han C, Xie B, Hu X, Yu Q, Shi L, Wang Q, Li D, Wang J, Zheng P, et al. 2013. Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell. 152:467-478.
13. Chen GY, Tang J, Zheng P, Liu Y. 2009. CD24 and Siglec-10 selectively repress tissue damage-induced immune responses. Science. 323:1722-1725.
14. Chou HH, Hayakawa T, Diaz S, Krings M, Indriati E, Leakey M, Paabo S, Satta Y, Takahata N, Varki A. 2002. Inactivation of CMP-N-acetylneuraminic acid hydroxylase occurred prior to brain expansion during human evolution. Proc Natl Acad Sci USA. 99:11736-11741.
15. Crocker PR. 2005. Siglecs in innate immunity. Curr Opin Pharmacol. 5:431-437.
16. Crocker PR, Paulson JC, Varki A. 2007. Siglecs and their roles in the immune system. Nat Rev Immunol. 7:255-266.
17. Crocker PR, Redelinghuys P. 2008. Siglecs as positive and negative regulators of the immune system. Biochem Soc Trans. 36:1467-1471.
18. Crocker PR, Varki A, Wellcome T, Biocentre T, Sciences L. 2001. Siglecs in the immune system. Immunology. 103:137-145.
19. Ding C, Liu Y, Wang Y, Park BK, Wang C-Y, Zheng P, Liu Y. 2007. Siglecg limits the size of B1a B cell lineage by down-regulating NFkappaB activation. PLoS ONE. 2:e997.
20. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J. 2008. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 320:674-677.
21. Duong BH, Tian H, Ota T, Completo G, Han S, Vela JL, Ota M, Kubitz M, Bovin N, Paulson JC, et al. 2010. Decoration of T-independent antigen with ligands for CD22 and Siglec-G can suppress immunity and induce B cell tolerance in vivo. J Exp Med. 207:173-187.
22. Ferry H, Crockford TL, Silver K, Rust N, Goodnow CC, Cornall RJ. 2005. Analysis of Lyn/CD22 double-deficient B cells in vivo demonstrates Lyn-and CD22-independent pathways affecting BCR regulation and B cell survival. Eur J Immunol. 35:3655-3663.
23. Hoffmann A, Kerr S, Jellusova J, Zhang J, Weisel F, Wellmann U, Winkler TH, Kneitz B, Crocker PR, Nitschke L. 2007. Siglec-G is a B1 cell-inhibitory receptor that controls expansion and calcium signaling of the B1 cell population. Nat Immunol. 8:695-704.
24. Inohara N, Ogura Y, Nunez G. 2002. Nods: A family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol. 5:76-80.
25. Janeway CA. 1989. Approaching the asymptote? Evolution and revolution in immunology. Cold Spring Harb Symp Quant Biol. 54:1-13.
26. Janeway CA, D.E.1992. The immune system evolved to discriminate infectious nonself from noninfectious self. Immunol Today. 13:11-16.
27. Jellusova J, Duber S, Guckel E, Binder CJ, Weiss S, Voll R, Nitschke L. 2010. Siglec-G regulates B1 cell survival and selection. J Immunol. 185:3277-3284.
28. Jellusova J, Wellmann U, Amann K, Winkler TH, Nitschke L. 2010. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity. J Immunol. 184:3618-3627.
29. Kato H, Takahasi K, Fujita T. 2011. RIG-I-like receptors: Cytoplasmic sensors for non-self RNA. Immunol Rev. 243:91-98.
30. Li N, Zhang W, Wan T, Zhang J, Chen T, Yu Y, Wang J, Cao X. 2001. Cloning and characterization of Siglec-10, a novel sialic acid binding member of the Ig superfamily, from human dendritic cells. J Biol Chem. 276:28106-28112.
31. Matzinger P. 1994. Tolerance, danger, and the extended family. Annu Rev Immunol. 12:991-1045.
32. McMillan SJ, Sharma RS, McKenzie EJ, Richards HE, Zhang J, Prescott A, Crocker PR. 2013. Siglec-E is a negative regulator of acute pulmonary neutrophil inflammation and suppresses CD11b beta2-integrin-dependent signaling. Blood. 121:2084-2094.
33. Medzhitov R, Preston-Hurlburt P, Janeway CA, D.E.1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature. 388:394-397.
34. Meesmann HM, Fehr E-M, Kierschke S, Herrmann M, Bilyy R, Heyder P, Blank N, Krienke S, Lorenz H-M, Schiller M. 2010. Decrease of sialic acid residues as an eat-me signal on the surface of apoptotic lymphocytes. J Cell Sci. 123:3347-3356.
35. Meylan E, Tschopp J, Karin M. 2006. Intracellular pattern recognition receptors in the host response. Nature. 442:39-44.
36. Millar DG, Garza KM, Odermatt B, Elford AR, Ono N, Li Z, Ohashi PS. 2003. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat Med. 9:1469-1476.
37. Mittal D, Saccheri F, Venereau E, Pusterla T, Bianchi ME, Rescigno M. 2010. TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells. EMBO J. 29:2242-2252.
38. Munday J, Kerr S, Ni J, Cornish AL, Zhang JQ, Nicoll G, Floyd H, Mattei MG, Moore P, Liu D, et al. 2001. Identification, characterization and leucocyte expression of Siglec-10, a novel human sialic acid-binding receptor. Biochem J. 355:489-497.
39. Nitschke L. 2009. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions. Immunol Rev. 230:128-143.
40. O'Keefe TL, Williams GT, Davies SL, Neuberger MS. 1996. Hyperresponsive B cells in CD22-deficient mice. Science. 274:798-801
41. O'Reilly MK, Paulson JC. 2009. Siglecs as targets for therapy in immune-cell-mediated disease. Trends Pharmacol Sci. 30:240-248.
42. Page RD. 1996. TreeView: An application to display phylogenetic trees on personal computers. Comput Applic Biosci. 12:357-358.
43. Pfrengle F, Macauley MS, Kawasaki N, Paulson JC. 2013. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22. J Immunol. 191:1724-1731.
44. Pilatte Y, Tisserand EM, Greffard A, Bignon J, Lambre CR. 1990. Anticarbohydrate autoantibodies to sialidase-treated erythrocytes and thymocytes in serum from patients with pulmonary sarcoidosis. Am J Med. 88:486-492.
45. Pillai S, Cariappa A, Pirnie SP. 2009. Esterases and autoimmunity: The sialic acid acetylesterase pathway and the regulation of peripheral B cell tolerance. Trends Immunol. 30:488-493.
46. Pillai S, Netravali IA, Cariappa A, Mattoo H. 2012. Siglecs and immune regulation. Annu Rev Immunol. 30:357-392.
47. Poe JC, Tedder TF. 2012. CD22 and Siglec-G in B cell function and tolerance. Trends Immunol. 33:413-420.
48. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science. 282:2085-2088.
49. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. 2009. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc. 4:31-36.
50. Rogentine GN, Jr, Plocinik BA. 1974. Carbohydrate inhibition studies of the naturally occurring human antibody to neuraminidase-treated human lymphocytes. J Immunol. 113:848-858.
51. Scaffidi P, Misteli T, Bianchi ME. 2002. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 418:191-195.
52. Sims GP, Rowe DC, Rietdijk ST, Herbst R, Coyle AJ. 2010. HMGB1 and RAGE in inflammation and cancer. Annu Rev Immunol. 28:367-388
53. Springer GF. 1984. Tand Tn, general carcinoma autoantigens. Science. 224:1198-1206.
54. Takahashi K, Fukushima S, Yamahara K, Yashiro K, Shintani Y, Coppen SR, Salem HK, Brouilette SW, Yacoub MH, Suzuki K. 2008. Modulated inflammation by injection of high-mobility group box 1 recovers post-infarction chronically failing heart. Circulation. 118:S106-S114.
55. Thompson JD, Higgins DG, Gibson TJ. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
56. Urbonaviciute V, Furnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, et al. 2008. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: Implications for the pathogenesis of SLE. J Exp Med. 205:3007-3018.
57. Vaith P, Uhlenbruck G. 1978. The Thomsen agglutination phenomenon: A discovery revisited 50 years later. Z Immunitatsforsch Immunobiol. 154:1-15.
58. Varki A. 2007. Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins. Nature. 446:1023-1029.
59. Varki A, Angata T. 2006. Siglecs-the major subfamily of I-type lectins. Glycobiology. 16:1R-27R.
60. von Gunten S, Bochner BS. 2008. Basic and clinical immunology of Siglecs. Ann NY Acad Sci. 1143:61-82.
61. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, et al. 1999. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 285:248-251.
62. Whitney G, Wang S, Chang H, Cheng KY, Lu P, Zhou XD, Yang WP, McKinnon M, Longphre M. 2001. A new siglec family member, siglec-10, is expressed in cells of the immune system and has signaling properties similar to CD33. Eur J Biochem. 268:6083-6096.